nafamostat has been researched along with Endotoxemia in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanowatari, Y | 1 |
| Nemoto, K | 1 |
| Hara, S | 1 |
| Ninomiya, N | 1 |
| Yamamoto, Y | 1 |
1 other study available for nafamostat and Endotoxemia
| Article | Year |
|---|---|
Effects of direct haemoperfusion through fibres immobilizing polymyxin B and nafamostat mesilate on endotoxaemia in conscious Guinea-pigs.
Topics: Animals; Anticoagulants; Benzamidines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Colon; | 2008 |